Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ GEFITINIB SANDOZ CANADA INCORPORATED Resolved 250MG Updated Report 2025-11-18 270837
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Resolved 20MG Updated Report 2025-11-18 268623
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Resolved 10MG Updated Report 2025-11-18 268620
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Resolved 25MG Updated Report 2025-11-18 268033
PROLENSA BAUSCH & LOMB INC Actual shortage 0.07% Updated Report 2025-11-18 271445
!!T3 ROPIVACAINE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 10MG Updated Report 2025-11-18 257455
!!T3 ROPIVACAINE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 2MG Updated Report 2025-11-18 268276
!!T3 NAROPIN ASPEN PHARMACARE CANADA INC. Actual shortage 10MG New Report 2025-11-18 270404
!!T3 NAROPIN ASPEN PHARMACARE CANADA INC. Actual shortage 10MG New Report 2025-11-18 271416
OGIVRI BIOSIMILAR COLLABORATIONS IRELAND LIMITED Actual shortage 20ML 440MG Updated Report 2025-11-18 269871
SANDOZ BRIMONIDINE SANDOZ CANADA INCORPORATED Actual shortage 0.2% Updated Report 2025-11-18 271982
SANDOZ CANDESARTAN SANDOZ CANADA INCORPORATED Actual shortage 16MG Updated Report 2025-11-18 271985
SANDOZ CANDESARTAN SANDOZ CANADA INCORPORATED Actual shortage 4MG Updated Report 2025-11-18 271988
SANDOZ DUTASTERIDE SANDOZ CANADA INCORPORATED Actual shortage 0.5MG Updated Report 2025-11-18 271991
SANDOZ ESOMEPRAZOLE SANDOZ CANADA INCORPORATED Actual shortage 40MG Updated Report 2025-11-18 271994
SANDOZ PANTOPRAZOLE SANDOZ CANADA INCORPORATED Actual shortage 40MG Updated Report 2025-11-18 271997
SANDOZ SITAGLIPTIN-METFORMIN XR SANDOZ CANADA INCORPORATED Actual shortage 1000MG 50MG Updated Report 2025-11-18 272000
SANDOZ TACROLIMUS SANDOZ CANADA INCORPORATED Actual shortage 1MG Updated Report 2025-11-18 272003
TIMOLOL MALEATE-EX SANDOZ CANADA INCORPORATED Actual shortage 0.5% Updated Report 2025-11-18 272009
METHOTREXATE INJECTION BP ACCORD HEALTHCARE INC Resolved 25MG Updated Report 2025-11-18 218309

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
VIRAZOLE BAUSCH HEALTH, CANADA INC. To be discontinued 6G New Report 2025-11-18 272123
SANDOZ GEFITINIB SANDOZ CANADA INCORPORATED Discontinued 250MG New Report 2025-11-18 272120
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2025-11-18 257374
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Discontinued 10MG Updated Report 2025-11-18 257368
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Discontinued 25MG Updated Report 2025-11-18 257377
TARO-LANSOPRAZOLE SUN PHARMA CANADA INC To be discontinued 30MG Updated Report 2025-11-17 272029
TARO-LANSOPRAZOLE SUN PHARMA CANADA INC To be discontinued 15MG New Report 2025-11-17 272026
CLINDOXYL GEL GLAXOSMITHKLINE INC Discontinued 5% 1% Updated Report 2025-11-14 270515
GLUCOPHAGE SANOFI-AVENTIS CANADA INC To be discontinued 850MG New Report 2025-11-14 271873
ARAVA SANOFI-AVENTIS CANADA INC To be discontinued 10MG New Report 2025-11-14 271870